BRIEF published on 10/08/2026 at 07:35, 11 days 20 hours ago Klea Holding Reports Rebound and Targets Growth in Q4 2026 Revenue Growth Klea Holding Middle East Expansion Q3 2026 Wellness Activities
BRIEF published on 10/08/2026 at 07:35, 11 days 20 hours ago Klea Holding: Rebound in Q3 2026 and positive outlook Growth Wellness Smart Salem Klea Holding Klea Pharmaceuticals
PRESS RELEASE published on 10/08/2026 at 07:30, 11 days 20 hours ago Klea Holding confirms its gradual rebound in Q3 2026 and targets revenue growth in Q4 2026 KLEA HOLDING reports Q3 2026 revenue results showcasing growth in Wellness activities and upcoming launch of Klea Health brand for preventive health. Expecting growth in Q4 2026 Klea Holding Klea Health Wellness Activities Q3 2026 Revenue Growth In Q4 2026
BRIEF published on 10/05/2026 at 18:05, 14 days 9 hours ago Klea Holding: Declaration of Transactions in Own Shares Share Buyback Middle East XPAR Market Klea Holding Article 5 MAR
BRIEF published on 09/28/2026 at 18:05, 21 days 9 hours ago Klea Holding: Share buybacks declared Financial Statement Middle East Euronext Growth Share Buybacks Klea Holding
BRIEF published on 09/28/2026 at 07:35, 21 days 20 hours ago Klea Holding's Strategic Growth Amidst Challenging Conditions Investment Strategy Profitability Healthcare Expansion Klea Holding Revenue 2026
BRIEF published on 09/28/2026 at 07:35, 21 days 20 hours ago Klea Holding's resilience in the first half of 2026 Middle East Profitability Strategic Investments Klea Holding Semester 2026
PRESS RELEASE published on 09/28/2026 at 07:30, 21 days 20 hours ago Still profitable in H1 2026, Klea Holding invests in its future growth drivers Klea Holding reports €8.6M revenue in H1 2026 despite regional conflicts, with positive EBITDA & net profit. Focus on cost control, debt reduction, strategic initiatives for profitable growth EBITDA Revenue Profitable Growth Strategic Initiatives Klea Holding
BRIEF published on 09/22/2026 at 18:05, 27 days 9 hours ago KLEA HOLDING: Share Buybacks in September 2026 Share Buyback Financial Transactions Middle East Euronext Market Klea Holding
BRIEF published on 09/14/2026 at 18:05, 1 month 5 days ago Transactions in KLEA HOLDING's own shares Economic Growth XPAR Market MAR Regulations Klea Holding Own Actions
Published on 10/19/2026 at 23:20, 4 hours 21 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 4 hours 41 minutes ago Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 4 hours 51 minutes ago Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 5 hours 40 minutes ago Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Published on 10/19/2026 at 22:16, 5 hours 24 minutes ago EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 6 hours 18 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 18:05, 9 hours 35 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 9 hours 56 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:30, 10 hours 11 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/19/2026 (French only)
Published on 10/19/2026 at 18:40, 9 hours ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 9 hours 41 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 17:45, 9 hours 56 minutes ago Declaration of transactions on own shares from October 12, 2026 to October 18, 2026
Published on 10/19/2026 at 17:40, 10 hours 1 minute ago Schneider Electric launches a c. €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
